Core Viewpoint - Dyadic International, Inc. is actively participating in several prominent industry events to showcase its biotechnology capabilities in large-scale protein manufacturing for various applications, including vaccines and therapeutics [1][2]. Company Overview - Dyadic International, Inc. focuses on the efficient large-scale manufacture of proteins for human and animal vaccines, therapeutics, and non-pharmaceutical applications such as food, nutrition, and wellness [3][5]. - The company utilizes microbial gene expression and protein production platforms based on the fungus Thermothelomyces heterothallica, with its lead platform being the C1-cell protein production platform [4]. Technology and Applications - Dyadic's C1-cell protein production platform is designed to enhance the development, reduce production costs, and improve the performance of biologic vaccines and drugs for both human and animal health markets [4]. - The Dapibus™ protein production platform has been developed for the rapid and large-scale manufacture of low-cost proteins and other biologic products for non-pharmaceutical uses [4]. Industry Events - Dyadic will participate in the World AGRI-Tech Innovation Summit on March 11-12, 2025, and the Future Food-Tech event on March 13-14, 2025, both in San Francisco, CA [2]. - The company will also be involved in the Microbial Engineering III event from March 30 to April 3, 2025, in Porto, Portugal [2].
Dyadic to Attend Multiple Industry Events in March